Journal of Affective Disorders
Volume 84, Issue 2 , Pages 251-257 , February 2005

A closer look at treatment resistant depression: is it due to a bipolar diathesis?

Received 21 August 2003 ,Accepted 28 January 2004.

References 

  1. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J. Clin. Psychopharmacol. 1996;16(Suppl. 1):4s–14s
  2. Akiskal HS. The bipolar spectrum—the shaping of a new paradigm. Curr. Psychiatry Rep. 2002;4:1–3
  3. Akiskal HS, Mallya G. Criteria for the “soft” bipolar spectrum: treatment implications. Psychopharmacol. Bull. 1987;23:68–73
  4. Akiskal HS, Pinto O. The evolving bipolar spectrum: prototypes I, II, III, IV. Psychiatr. Clin. North Am. 1999;22:517–534
  5. Amsterdam JD, Hornig-Rohan M. Treatment algorithms in treatment-resistant depression. In:  Hornig-Rohan M,  Amsterdam JD editor. Psychiatr. Clin. North Am.. Philadelphia: Saunders; 1996;p. 371–386
  6. Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, et al. The impact of treatment-resistant depression on health care utilization and costs. J. Clin. Psychiatry. 2002;63(11):963–971
  7. Fagiolini A, Kupfer DJ. Is treatment-resistant depression a unique subtype of depression?. Biol. Psychiatry. 2003;53(8):640–648
  8. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr. Clin. North Am. 1996;19(2):179–200
  9. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders–Patient Version (SCID-I/P). New York: New York State Psychiatric Institute Biometrics Research; 1994;
  10. Frankle WG, Perlis RH, Deckersbach T, Grandin LD, Gray SM, Sachs GS, et al. Bipolar depression: relationship between episode length and antidepressant treatment. Psychol. Med. 2002;32(8):1417–1423
  11. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?. J. Affect. Disord. 1999;52:135–144
  12. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J. Clin. Psychiatry. 2001;62(7):565–569
  13. Ghaemi SN, Ko JY, Goodwin FK. “Cade's Disease” and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can. J. Psychiatry. 2002;47:125–134
  14. Ghaemi SN, Ko JK, Baldassano CF, Kontos NJ, Goodwin FK. Bipolar spectrum disorder: a pilot study. In: Poster presentation at the 155th Annual American Psychiatric Association Meeting, Philadelphia, PA. 2002;
  15. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford Univ. Press; 1990;
  16. Hantouche EG, Akiskal HS, Lancrenon S, Allilaire JF, Sechter D, Azorin JM, et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J. Affect. Disord. 1998;50(2–3):163–173
  17. Hart AB, Craighead WE, Craighead LW. Predicting recurrence of major depressive disorder in young adults: a prospective study. J. Abnorm. Psychology. 2001;110:633–643
  18. Hemels M, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981–2000. Ann. Pharmacother. 2002;36:1375–1379
  19. Kennedy N, Abbott R, Paykel E. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol. Med. 2003;33:827–838
  20. Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J. Clin. Psychiatry. 2001;62(Suppl. 16):18–25
  21. Murray CJ, Lopez AD. Evidence-based health policy—lessons from the Global Burden of Disease Study. Science. 1996;274:740–743
  22. Sharma V. Loss of response to antidepressants and subsequent refractoriness: diagnostic and treatment issues. J. Affect. Disord. 2001;64:99–106
  23. Wehr TK, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch. Gen. Psychiatry. 1979;36:555–559

PII: S0165-0327(04)00086-2

doi: 10.1016/j.jad.2004.01.015

Journal of Affective Disorders
Volume 84, Issue 2 , Pages 251-257 , February 2005